IL1B and Myocardial fibrosis: The reduction in pro-inflammatory monocytes led, on one hand, to a decrease in pro-inflammatory cytokines such as IL-1 and IL-6, which in turn reduced myocardial fibrosis, which would ultimately contribute to reduced myocardial fibrosis and improved cardiac function.